Cerulean Pharma reported $-8400450 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Arrowhead Research ARWR:US $ -72909000 114.46M
Bayer BAYN:GR 2.28B 1.89B
Biocept BIOC:US $ -2707000 68.54K
Brainstorm Cell Therapeutics BCLI:US $ -7591000 2.12M
Cerulean Pharma CERU:US $ -8400450 1.14M
Immunogen IMGN:US $ -61053000 38.2M
Johnson & Johnson JNJ:US $ 6941M 599M
Macrogenics MGNX:US $ -41808000 24.83M
Merk MRK:US $ 5711M 652M
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Perrigo Ordinary Shares PRGO:US $ 2.6M 20.5M
Pfizer PFE:US $ 12099M 2104M
Seattle Genetics SGEN:US $ -133111000 61K
YTE INCY:US $ 260.29M 132.62M